Verdence Capital Advisors LLC Invests $430,000 in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Verdence Capital Advisors LLC purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 14,191 shares of the company's stock, valued at approximately $430,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Treasurer of the State of North Carolina grew its holdings in shares of Acadia Healthcare by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock worth $1,586,000 after buying an additional 250 shares in the last quarter. Coldstream Capital Management Inc. grew its holdings in Acadia Healthcare by 4.9% in the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock valued at $257,000 after purchasing an additional 303 shares during the period. Covestor Ltd grew its holdings in Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares during the period. Xponance Inc. grew its holdings in Acadia Healthcare by 5.9% in the fourth quarter. Xponance Inc. now owns 10,530 shares of the company's stock valued at $418,000 after purchasing an additional 590 shares during the period. Finally, Quantinno Capital Management LP grew its holdings in Acadia Healthcare by 9.0% in the fourth quarter. Quantinno Capital Management LP now owns 8,695 shares of the company's stock valued at $345,000 after purchasing an additional 721 shares during the period.

Acadia Healthcare Trading Down 3.7%

ACHC stock traded down $0.85 during midday trading on Friday, reaching $21.92. 1,278,458 shares of the company's stock traded hands, compared to its average volume of 1,870,740. The company has a market capitalization of $2.02 billion, a P/E ratio of 10.80, a PEG ratio of 4.18 and a beta of 0.93. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41. The business has a 50-day moving average price of $23.07 and a two-hundred day moving average price of $30.14.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The business had revenue of $770.51 million for the quarter, compared to analysts' expectations of $769.90 million. During the same period in the previous year, the company posted $0.84 earnings per share. The business's revenue for the quarter was up .3% compared to the same quarter last year. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Ratings Changes

ACHC has been the subject of a number of recent analyst reports. Mizuho lowered their target price on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Guggenheim initiated coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price for the company. Barclays lowered their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a report on Wednesday, May 14th. Finally, KeyCorp lowered their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, Acadia Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.